What Is Formaldehyde?

An Essay on an embalming fluid, a Group 1 carcinogen, and an ingredient in the vaccines given to newborns

This essay examines a specific chemical ingredient on the childhood vaccine schedule. The case against formaldehyde can be built within the terms the regulatory system itself uses, and most of the evidence below is drawn from that system: the CDC’s own Pink Book, the WHO’s cancer research arm, the EPA’s exposure limits, OSHA’s workplace rules. These are quoted and attributed as what they are. My analytical voice operates within the terrain framework that governs this body of work. Where mainstream vocabulary appears in this essay (virus, antigen, immune response, antibody, infection), it belongs to the sources being quoted, not to me. The chemistry of formaldehyde is real. The regulatory documents are real. The question of what is in the vial, and what it does to the body it is injected into, can be answered without accepting the framework that put it there.

Two vials

The vial of embalming fluid at the funeral home and the vial of hepatitis B vaccine injected into the newborn contain the same chemical compound. Formaldehyde. The embalmer uses it to preserve tissue by cross-linking the proteins so that bacteria and fungi cannot break them down. The vaccine manufacturer uses it to kill bacterial contamination during production and to alter the biological material the industry labels as hepatitis B virus. The leftover formaldehyde stays in the vial. The vial goes into the muscle tissue of a child, often within hours of birth, before the first feed, before the mother has recovered from labor.

The ingredient is listed. The schedule is published. The CDC’s own 14th-edition Pink Book, in Appendix B, names formaldehyde as an excipient in Recombivax (hepatitis B), in Daptacel and Infanrix (DTaP), in Pediarix and Vaxelis and Pentacel (combination vaccines given at two, four, and six months), in Ipol (polio), in Boostrix and Adacel and Tenivac and TDVAX (tetanus-containing), in Fluzone and Fluarix and FluLaval and Fluad (influenza, administered annually from six months of age), in Menactra and MenQuadfi and Menveo (meningococcal), in Vaqta (hepatitis A), in ActHIB and Hiberix (Hib), in Ixiaro (Japanese encephalitis), in Biothrax (anthrax), in DT, and in Typhim Vi (typhoid). The same table lists Havrix (hepatitis A) and Twinrix (hepatitis A/B combination) under the term formalin, which is formaldehyde in aqueous solution.¹ The chemical appears on the schedule from the first day of life and recurs through adolescence.

The hepatitis B vaccine is administered within twenty-four hours of birth to the majority of infants born in American hospitals. The Pink Book reports that 75% of children born in 2015 and 2016 received the birth dose within three days of life, a figure that has climbed since.² The Recombivax formulation listed on the CDC’s excipient table contains formaldehyde, potassium aluminum sulfate, amorphous aluminum hydroxyphosphate sulfate, and yeast protein.¹ The child goes home from the hospital with these substances in her tissue.

Support This Work

The essays are free and will stay free. What paid subscribers get is the library that surrounds them: the full digital book catalogue, audio deep dives, archived, and embedded in each essay, and the Questions for Your Doctor, Before You Consent, and Package Insert series. Platinum Supporters also receive the digital edition of every paperback on the day it’s published.

Whichever tier suits, thank you for being here. If you’d like to become a paid subscriber, upgrade a tier, or gift a subscription to someone who might value the work, the options are below.

Audio Deep Dive (for Paid Subscribers)

What it is

Formaldehyde is CH₂O, the simplest aldehyde. At room temperature it is a colorless gas with a sharp odor detectable at concentrations as low as 0.5 parts per million. Dissolved in water at approximately 37%, it becomes formalin, the liquid familiar to anatomy labs and funeral homes. The chemical was first synthesized in 1859 and patented for industrial use shortly after. Its utility across industry rests on two properties: it kills microorganisms, and it cross-links proteins.

The embalming industry built around chemical body preservation in the 1860s and 1870s used it for exactly these reasons. The chemical binds amino and thiol groups on tissue proteins and freezes them in place. Bacteria and fungi cannot digest cross-linked protein. Decomposition stops. The same two properties made formaldehyde useful across other industries: as a precursor for the resins that bind particleboard, plywood, and laminate; as a textile finish, including the permanent-press treatments on clothing; as a disinfectant in laboratories and mortuaries; as a preservative in some cosmetics and in some veterinary feeds.

Global production runs in the range of 30 million metric tons a year, placing it among the most-produced chemicals in the world. A modern home contains it in dozens of places. Pressed-wood furniture, kitchen cabinets, carpet backing, drywall adhesives, and the formaldehyde-releasing preservatives inside shampoo and body wash all off-gas the chemical slowly into indoor air. Measurements inside new homes commonly run five to ten times outdoor air concentrations. None of this changes what the chemical does to tissue.

In 2004, the International Agency for Research on Cancer, the cancer research arm of the World Health Organization, reclassified formaldehyde as Group 1: carcinogenic to humans.³ Group 1 is the highest category IARC uses, reserved for substances with sufficient evidence of causing cancer in people. The company it keeps in Group 1 includes asbestos, plutonium, tobacco smoke, and benzene. The classification was based on evidence of nasopharyngeal cancer in formaldehyde-exposed workers and of leukemia in industrial exposure cohorts. The pivotal cohort study by Hauptmann and colleagues at the National Cancer Institute, published in 2003, tracked more than 25,000 industrial workers across ten US plants and found a significant excess of myeloid leukemia mortality in the highest peak-exposure group.⁴

OSHA treats formaldehyde as a hazardous substance in American workplaces. Permissible airborne exposure is capped at 0.75 parts per million as an eight-hour time-weighted average, with a short-term limit of 2 parts per million for any fifteen-minute period.⁵ A workplace using the chemical must provide respiratory protection, local exhaust ventilation, eye protection, hazard training, and medical surveillance for exposed employees. The material safety data sheet lists it as toxic by inhalation, skin contact, and ingestion, with warnings for eye damage, respiratory sensitization, allergic skin reactions, and cancer risk.

Across all of this, no regulatory body has published a safety assessment for injected formaldehyde in human infants. The exposure routes the regulators studied are inhalation (workplace air, indoor air, cigarette smoke) and ingestion (drinking water, food). Intramuscular injection into a newborn is not among them.

What it does

Formaldehyde works on tissue the same way it works on an embalmed body. It cross-links proteins. The aldehyde carbon reacts with amino and thiol groups in amino acid side chains and forms covalent bonds between adjacent protein molecules. The cross-linked proteins lose their function. Enzymes that depended on folding and movement are frozen. Membrane proteins that transported ions or signaled across cells are immobilized. The mechanism is uncontroversial and documented across more than a century of biochemistry.

The same reactivity damages the cell’s nucleic acids. Formaldehyde cross-links the nucleic acid strand to the proteins packed around it, and the cell cannot easily repair the lesion. Cells carrying this damage die outright or divide producing further damaged cells. The IARC monograph cites this chemistry in its Group 1 classification. The link between workplace formaldehyde exposure and leukemia in exposed cohorts follows from the same reactions reaching bone marrow cells over years.

When formaldehyde reaches tissue at a concentration that overwhelms local clearing capacity, it kills cells. The embalmer relies on this cellular toxicity for preservation, and industrial safety limits are calibrated around it. The vaccine manufacturer uses the chemical for the same reason: to kill bacterial contamination during production and to alter the biological materials being prepared. The industry describes this as inactivating what it calls polio virus, as weakening diphtheria toxin into diphtheria toxoid, and as weakening tetanus toxin into tetanus toxoid. After formaldehyde treatment, the materials in the vial no longer produce the acute illness they are said to produce when fresh.

A newborn has approximately 240 milliliters of blood. Her liver, the primary site of formaldehyde metabolism in older humans, is immature at birth. The enzyme that clears the chemical (formaldehyde dehydrogenase, which converts the aldehyde to formic acid and then to carbon dioxide and water) is present at reduced levels in neonates compared to adults. Her blood-brain barrier is permeable in ways it will not be after the first year. Her kidneys concentrate and excrete at lower rates. The margin between a dose the body can clear and a dose it cannot is narrower in the first weeks than at any other time of life.

Into this biology, the hepatitis B vaccine delivers residual formaldehyde directly into muscle tissue. The chemical reaches systemic circulation before any clearing organ acts on it. The muscle at the injection site contains aluminum adjuvant, which keeps the local tissue inflamed for weeks. Inflamed tissue has altered blood flow and altered clearance kinetics. The formaldehyde acts on cells in that environment, not in the clean laboratory conditions of the inactivation chemistry performed inside the vial.

“Your body already makes it”

Every mainstream defense of formaldehyde in vaccines runs through the same argument. The CDC’s public-facing page states it, pediatric practice handouts repeat it, and fact-check articles reproduce it almost word for word. The argument runs: the human body produces formaldehyde endogenously as part of normal metabolism, at concentrations in the range of 2 to 3 micrograms per milliliter of blood; a vaccine dose of residual formaldehyde adds a trivially small amount to a background that is already larger; therefore no injury can occur.

The argument confuses four distinct biological facts. Each confusion closes a different door.

Endogenous production is not the same as exogenous delivery. Endogenous formaldehyde is generated inside cells, in regulated quantities, from one-carbon metabolism and from the oxidation of serine, glycine, and choline. It is produced by the same cell that clears it, in the same compartment, as part of a metabolic cycle the cell runs continuously. The formaldehyde never leaves the compartment that produced it. The body does not accumulate a free formaldehyde pool. The 2 to 3 micrograms per milliliter figure cited in the defense is a transient steady-state concentration maintained by enzymes clearing the chemical as fast as it is produced. Exogenous formaldehyde delivered as an injection enters tissue as a bolus. It is not produced by the cell that must clear it. It arrives in excess of local clearing capacity by definition, which is why the chemical acts on tissue at all.

Oral and inhalation routes are not the same as intramuscular injection. The EPA’s reference dose for formaldehyde in drinking water assumes oral ingestion.⁶ The oral route delivers the chemical to the portal circulation, which carries it directly to the liver before it reaches the rest of the body. The liver clears most of it on the first pass. OSHA’s workplace limit assumes inhalation. Inhaled formaldehyde is cleared in the upper airway by mucosal enzyme systems. Neither pathway resembles intramuscular injection, in which the chemical is deposited in muscle tissue and reaches systemic circulation before encountering any clearing organ. The regulators themselves distinguish between exposure routes. The vaccine defense treats them as interchangeable.

With cofactors is not the same as without. Endogenous formaldehyde is produced inside cells that contain the enzymes, cofactors, and substrates needed to clear it. The clearance system is integrated with the production system. Injected formaldehyde arrives in tissue without any of this. The muscle at the injection site contains no formaldehyde dehydrogenase at concentrations relevant to a bolus dose, and the aluminum adjuvant present in the same vial extends the inflammation window during which the chemical is acting on nearby cells.

Transient equilibrium is not the same as repeated pulses. Endogenous formaldehyde is produced continuously at low rates and cleared continuously at matching rates. The system is in dynamic balance. The vaccine schedule introduces formaldehyde on day one of life, again at two months, again at four months, again at six months, again at twelve to fifteen months, again at four to six years, and annually thereafter through the influenza schedule. Each injection is a pulse. The DTaP vaccine Infanrix, administered at two, four, and six months, specifies up to 100 micrograms of residual formaldehyde per 0.5 milliliter dose in its own package insert.¹⁶ The pulses stack across a developing body whose clearing systems are still maturing. No study has characterized the cumulative tissue exposure across the full schedule. The defense cites the endogenous steady state as if it absorbed the pulses, which it was never designed to do.

Behind the four confusions sits a deeper error. The defense treats a molecule as a context-free unit. A molecule of CH₂O with the formula CH₂O. Interchangeable regardless of where it came from, how it arrived, what came with it, or what the receiving tissue was prepared to do with it. The body does not treat molecules this way. The route of entry, the cofactor matrix, the timing, and the local tissue state are not incidental to biology. They are the biology. The body is a self-regulating organism that cleanses, repairs, and maintains the terrain within tolerances it has evolved to handle. The tolerances were not shaped by injection. The route did not exist until the needle created it.

How it got there and stayed

Formaldehyde entered vaccine production in the early twentieth century for a straightforward reason. It worked. It killed bacterial contamination in the production environment, and it altered the biological materials the industry worked with. The method was adopted at the Pasteur Institute in the early 1920s for the diphtheria toxoid. The CDC’s Pink Book states directly that “a method for inactivating tetanus toxin with formaldehyde was developed in the early 1920s. This led to the development of tetanus toxoid in 1924.”⁷ The chapter on polio describes the inactivated vaccine as containing “wild poliovirus strains grown individually in Vero cells and inactivated with formaldehyde.”⁸ The practice is openly described in the establishment’s own training materials.

The Salk polio history is instructive and documented. Suzanne Humphries, in Dissolving Illusions, assembles the record of warnings issued by senior scientists during the vaccine’s development. Swedish observations presented at the Rome Poliomyelitis Congress in September 1954 showed that formaldehyde did not inactivate at the rate Salk’s model assumed, and that the inactivation curve was not a straight line but a continuous curvature.⁹ Dr. Edwin Lennette, director of the California State Department of Health, later recounted a 1953 meeting with Thomas Rivers, whom Humphries describes as the mastermind of Rockefeller’s polio vaccine mission. The question of whether the vaccine was adequately inactivated at the chosen formaldehyde concentration was raised directly at that meeting. Rivers answered: “If you put any more formaldehyde in, you’ll make it so damn safe it won’t be any good.”¹⁰ The 1955 Cutter incident, in which Cutter Laboratories’ polio vaccine paralyzed children when the inactivation chemistry fell short, followed directly from this dismissal. The record shows 260 cases of paralysis documented between April 17 and June 30, 1955, after inoculation of roughly 400,000 persons with the Cutter vaccine. The official breakdown counted 94 cases among the vaccinated themselves, 126 among family contacts, and 40 among community contacts.¹¹

Wendell Stanley described what formaldehyde had actually done to the vaccine material. It “engendered a ‘tanning’ effect upon the outer coating of the virus,” reversible under subsequent conditions, so the material could test clean at fourteen days and reactivate at three or four weeks.¹² Stanley’s observation went into the record and was set aside. The vaccine stayed on the schedule. Manufacturers responded to the Cutter disaster by adding more filtration steps rather than reconsidering the inactivation chemistry. Dr. Sven Gard, a leading Swedish scientist working on the Salk problem, later wrote that the repeated filtrations were “only hunting ghosts” and that “the whole philosophy behind the Salk vaccine is wrong.”¹³

The point is not that formaldehyde was poorly chosen for inactivation chemistry. The point is that no one at the time asked, and no one since has adequately asked, what the residual formaldehyde did when it reached the recipient’s tissue. The inactivation was studied in the vial. The injection consequences were not studied in the body.

The regulatory framework that stabilized this arrangement rests on two words. “Residual” and “trace.” Formaldehyde in a vaccine is classified as a manufacturing-process residual rather than as an active ingredient. The distinction matters legally and practically. Active ingredients require safety and efficacy studies. Residuals do not, as long as the manufacturer certifies that remaining concentrations fall below a defined threshold. The threshold was set by reference to endogenous production levels, which recycles the confusion addressed in the previous section. The second category is Generally Recognized as Safe. GRAS is an FDA designation created for food additives with a long history of consumption. Formaldehyde carries GRAS status for certain food applications. GRAS was never designed as a safety determination for injection. The chemical’s presence on the food-additive list has functioned in regulatory practice as a general safety signal that transfers across contexts it was never evaluated against.

What was not done is more revealing than what was. No randomized trial has tested injected formaldehyde in human infants against a true saline placebo. No biodistribution study has tracked where injected formaldehyde actually travels in the body over time. The 2013 pharmacokinetic modeling paper by Mitkus and colleagues at the FDA, which the CDC and vaccine manufacturers cite in defense of injection safety, is a computational projection built on assumptions about absorption, distribution, and clearance in the injected infant.¹⁷ It is not empirical measurement; it is what the field has substituted for empirical measurement. No cumulative-dose study has characterized total formaldehyde exposure across the full childhood schedule. No study has examined formaldehyde in combination with the aluminum adjuvants it is injected alongside, even though the aluminum keeps the injection site inflamed for weeks and extends the window during which the formaldehyde acts on local tissue. Neil Miller’s catalog of critical vaccine studies states this directly: “No studies have been conducted to confirm the safety of combining aluminum with other toxic substances in vaccines, such as mercury, formaldehyde, phenoxyethanol, polysorbate 80, and glutaraldehyde.”¹⁴

These are not gaps. They are choices. The studies that would answer the questions have not been funded. The regulatory structure does not require them. The manufacturers are not liable for injuries caused by the ingredients they place in the vial, because the 1986 National Childhood Vaccine Injury Act removed that liability from the civil courts and replaced it with a federal compensation program funded by an excise tax on vaccines themselves.¹⁵ The arrangement is organized so that the questions are not asked. The structure that would answer them does not exist.

Two vials, again

I find it demonically poetic that we are injected with formaldehyde on our entry into the world, and wrapped in formaldehyde on our exit.

A deeper paradigm question sits beneath all of this. The body is not under constant assault by invading pathogens requiring pharmaceutical defense. Disease arises from toxic exposure, nutritional deficiency, electromagnetic burden, and psychological strain, acting on a terrain the body works continuously to maintain. The injection of embalming fluid into a healthy newborn is an insult to that terrain. The question of whether a specific dose of formaldehyde causes a particular identifiable injury in an individual child is secondary to the question of why embalming fluid is in the vial at all. Other essays in this series address the deeper layer. This one has stayed with the chemical.

Return to the vial at the funeral home and the vial injected into the newborn. The chemical compound is identical. The embalmer uses the chemical for a stated purpose: to stop decomposition by freezing proteins in place. The vaccine manufacturer uses the chemical for a stated purpose: to kill bacterial contamination in production and to alter the biological material in the vial. The leftover chemical, in both vials, is formaldehyde. Every US agency with jurisdiction has published something about it. The CDC’s Pink Book lists it (as formaldehyde or formalin) in twenty-nine vaccines. The IARC monograph classifies it as Group 1, carcinogenic to humans. OSHA regulates workplace airborne exposure at 0.75 parts per million. EPA calibrates a reference dose for drinking water. None of these documents concerns the route the schedule actually uses. The injection into the newborn’s muscle, bypassing every regulatory limit calibrated to any other exposure route, happens on the day of birth, under a schedule the parents have been told is safe because the body already makes small amounts of the compound itself.

The ingredient is listed. The studies are not.

Twelve points

1. Formaldehyde is the chemical compound CH₂O. In solution at approximately 37%, it is formalin, the fluid used in anatomy labs and funeral homes.

2. The International Agency for Research on Cancer classified formaldehyde as a Group 1 carcinogen in 2004. Group 1 means carcinogenic to humans, the highest category IARC uses.

3. OSHA regulates formaldehyde as a hazardous substance in American workplaces. Permissible airborne exposure is capped at 0.75 parts per million over an eight-hour day. Employers using the chemical must provide respiratory protection, ventilation, training, and medical surveillance.

4. The CDC’s own Pink Book, Appendix B, lists formaldehyde as an excipient in Recombivax, Daptacel, Infanrix, Pediarix, Vaxelis, Pentacel, Ipol, Boostrix, Adacel, Tenivac, TDVAX, Fluzone, Fluarix, FluLaval, Fluad, Menactra, MenQuadfi, Menveo, Vaqta, ActHIB, Hiberix, Ixiaro, Biothrax, DT, Typhim Vi, Kinrix, and Quadracel. The same table lists Havrix and Twinrix (hepatitis A vaccines) under the term formalin, which is formaldehyde in aqueous solution.

5. The chemical cross-links proteins and reacts with cellular nucleic acids. This is why it preserves tissue in embalming and alters vaccine materials in production. The same chemistry damages cells over time at exposure concentrations.

6. The childhood vaccine schedule introduces formaldehyde on day one of life (hepatitis B birth dose), at two months, four months, six months, twelve to fifteen months, four to six years, and annually thereafter through influenza vaccines.

7. The mainstream defense of formaldehyde in vaccines rests on the claim that the body produces the chemical endogenously. The defense conflates endogenous production with injected delivery, oral and inhalation routes with intramuscular injection, metabolically embedded production with isolated bolus doses, and continuous steady-state balance with repeated schedule pulses.

8. The EPA’s and OSHA’s exposure limits apply to ingestion and inhalation routes with full metabolic clearance available. No regulatory body has published a corresponding safety limit for injected formaldehyde in human infants.

9. Formaldehyde entered vaccine production in the early twentieth century because it killed bacterial contamination and altered biological materials in the vial. The Salk polio vaccine history records that senior scientists warned the inactivation chemistry was wrong, that the inactivation was incomplete and the material in the vials remained capable of causing paralysis, and that the warnings were set aside.

10. Formaldehyde is classified in vaccines as a manufacturing residual rather than as an active ingredient. Residuals are not required to be safety-tested the way active ingredients are. The GRAS designation that permits formaldehyde in some food applications has functioned as a general safety signal transferring to injection contexts it was never evaluated against.

11. No randomized trial, no biodistribution study, no cumulative-dose assessment, and no study of formaldehyde in combination with aluminum adjuvants has been performed in human infants on the childhood schedule. The absence is structural, not accidental.

12. The 1986 National Childhood Vaccine Injury Act removed vaccine manufacturers’ civil liability for injuries caused by ingredients in the vial. The regulatory structure that approved formaldehyde for injection, the industry that profits from the schedule, and the parents who must live with the consequences do not share equal access to the courts.

Questions you will be asked

“Isn’t the amount tiny?” Residual formaldehyde in a single vaccine dose is listed by manufacturers in the microgram range. The Infanrix (DTaP) package insert specifies up to 100 micrograms per 0.5 milliliter dose; Daptacel and other DTaP preparations fall in a similar range. Whether that amount is tiny depends on where it goes, how fast it is cleared, what accompanies it, and what the receiving body is prepared to handle. A microgram in a glass of water the liver clears on first pass is a different biological event from a microgram injected into muscle tissue of a six-pound newborn alongside an aluminum adjuvant. The question of whether the amount is small presupposes an exposure route the regulators never studied for injection.

“Doesn’t the body already produce formaldehyde?” The body produces endogenous formaldehyde in regulated quantities, inside cells, cleared by enzymes in the same cell, as part of a metabolic cycle in dynamic balance. Injected formaldehyde arrives from outside, as a bolus, in tissue that was not producing it, in the presence of aluminum adjuvant that extends local inflammation and alters clearance kinetics. The two are not interchangeable. The endogenous steady state is not a reservoir that absorbs injections.

“Hasn’t this been studied?” Formaldehyde’s toxicity has been studied extensively by the EPA, OSHA, and IARC in the contexts of inhalation and ingestion. No regulatory body has published a safety study of injected formaldehyde in human infants. No biodistribution study, no cumulative-dose study across the schedule, and no study of combination with aluminum adjuvants exists. The absence is documented in Neil Miller’s catalog of the published literature.

“If it were dangerous, wouldn’t we see it?” We do see it. The rise in neurodevelopmental conditions, chronic inflammation, pediatric conditions labeled autoimmune, SIDS, and the broader chronic illness profile of the vaccinated cohort is what harm from the schedule looks like at population scale. The comparison between fully vaccinated and genuinely unvaccinated children is the comparison the regulatory agencies have refused to fund. Independent researchers (Mawson, Lyons-Weiler, Thomas, Garner) have performed versions of it and found consistent and significant health gaps.

“But vaccines prevent disease, right?” The question of whether the childhood schedule produces net health benefit is addressed in other essays in this series. The formaldehyde question is prior to it. If embalming fluid is in the vial, and no one has studied what happens when it is injected into a newborn, the question of what the vial is for cannot settle the question of what the ingredient does.

“Why would doctors give it if it were harmful?” Doctors are trained in a system that treats the schedule as settled science and treats the ingredient list as a manufacturing matter outside their clinical responsibility. The pediatrician reading the chart does not read the manufacturer’s insert. The pharmacist filling the vial does not read the IARC monograph. The system is structured so that the people administering the injection are not the people trained in what is in it.

How to Explain It to a Six-Year-Old

Imagine your body is a garden. A real garden, with soil and roots and little pathways the water travels along to reach the plants. The garden has a tiny spray bottle it uses sometimes to clean up small messes between the leaves. The spray bottle holds a cleaner that is helpful in very small amounts, used in the right place at the right time by the gardener who lives inside you. The gardener knows how to make a little of the cleaner, use a little, and clean up a little. The garden has worked this way for a very long time.

One day someone comes to the fence with a big spray gun. The gun contains the same cleaner, except a lot of it, and a kind that was made in a factory far away. The person at the fence says, “Don’t worry. Your garden already uses this stuff.” Then they point the big gun past the fence, past the gate, past the little path the garden has for letting things in and out slowly, and they spray it straight into the dirt around the roots. The cleaner goes into the garden all at once, in a place it does not belong, in an amount the gardener was never prepared to handle. The gardener was not asked.

The person at the fence says the garden is fine because the garden makes a little bit of the same cleaner on its own. But the garden making a tiny amount in the right place, slowly, with its own helpers nearby, is not the same thing as the big gun spraying a lot in the wrong place, quickly, with no helpers in sight. The gardener knows the difference. The plants know the difference. Everyone except the person with the spray gun seems to know the difference. The garden is a living thing. It does not care what the cleaner is called. It cares about where it came from, how much there is, and whether it belongs there. The answer, every time it is sprayed, is that it does not.

In Print

The Unbekoming library is available in paperback, printed to order through Lulu and shipped worldwide. The shelf begins with the paradigm question underneath everything else — No Virus, the isolation problem, the collapse of virology’s foundational claims, and a disease-by-disease reappraisal — and moves through the suppressed compounds mainstream medicine set aside: The DMSO Book, Chlorine Dioxide: The Forbidden Remedy, The Iodine Book, and The Hydrogen Peroxide Book. Two more recover what’s still on the kitchen shelf: Baking Soda and The Castor Oil Book. Two more recover the minerals modern soil, water, and processing quietly stripped from the diet: The Magnesium Handbook and The Boron Book. Sitting alongside these is No Contagion, co-authored with Jamie Andrews — the case against germ theory itself, catalogued through 258 failed contagion experiments.

The critique books cover what medicine, dentistry, psychiatry, and veterinary practice have become. The Unvaccinated treats the completely unvaccinated as a comparison group across twenty chapters and five appendices. Medicalized Motherhood follows a woman through 123 documented interventions from teenage pill to postpartum discharge. Drilling for Profit treats cavities, gum disease, and crooked teeth as the dietary problem they are. What Your Vet Can’t Tell You applies the same critique to pets. Escape from Psychiatry documents the fabrication of the DSM and the specific damage of every major psychiatric drug class. The Vitamin K Injection covers what happens in the first hours of a newborn’s life.

The full shelf is at lulu.com/spotlight/unbekoming. A physical book reaches the person a Substack post never will — the skeptical relative, the friend who won’t click a link but might open a book, the visitor whose eye lands on a coffee table. Buy one to keep, and one to give away.

References

1. Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-Preventable Diseases (The Pink Book), 14th edition. Appendix B: Vaccine Excipient Summary. Public Health Foundation, 2021.

2. Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-Preventable Diseases (The Pink Book), 14th edition. Chapter on Hepatitis B.

3. International Agency for Research on Cancer. IARC Monograph on the Evaluation of Carcinogenic Risks to Humans, Volume 88: Formaldehyde, 2-Butoxyethanol and 1-tert-Butoxypropan-2-ol. Lyon: World Health Organization, 2006. Based on the June 2004 Working Group reclassification.

4. Hauptmann, M., Lubin, J. H., Stewart, P. A., Hayes, R. B., Blair, A. Mortality from Lymphohematopoietic Malignancies among Workers in Formaldehyde Industries. Journal of the National Cancer Institute, 2003; 95(21): 1615-1623. The National Cancer Institute cohort study on which the IARC 2004 Working Group drew heavily for the leukemia classification.

5. US Occupational Safety and Health Administration. 29 CFR 1910.1048: Formaldehyde Standard.

6. US Environmental Protection Agency. Integrated Risk Information System (IRIS): Formaldehyde (CASRN 50-00-0). Oral reference dose assessment.

7. Centers for Disease Control and Prevention. Pink Book, 14th edition. Chapter on Tetanus.

8. Centers for Disease Control and Prevention. Pink Book, 14th edition. Chapter on Poliomyelitis.

9. Humphries, S. and Bystrianyk, R. Dissolving Illusions: Disease, Vaccines, and the Forgotten History. 2013. On the Rome Poliomyelitis Congress, September 1954, and the inactivation curve observations.

10. Humphries and Bystrianyk, Dissolving Illusions, 2013. Edwin Lennette interview recounting the 1953 pre-trial meeting with Thomas Rivers.

11. Humphries and Bystrianyk, Dissolving Illusions, 2013. Documentation of the 1955 Cutter incident, April to June, 260 cases of paralysis following inoculation of approximately 400,000 persons.

12. Humphries and Bystrianyk, Dissolving Illusions, 2013. Dr. Wendell Stanley on the “tanning” effect of formaldehyde on the outer protein coating.

13. Humphries and Bystrianyk, Dissolving Illusions, 2013. Dr. Sven Gard on the Salk inactivation philosophy.

14. Miller, N. Z. Miller’s Review of Critical Vaccine Studies: 400 Important Scientific Papers Summarized for Parents and Researchers. New Atlantean Press, 2016.

15. National Childhood Vaccine Injury Act of 1986, Public Law 99-660, Title III of the Public Health Service Act.

16. GlaxoSmithKline. Infanrix (Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed) Prescribing Information. Current revision. The package insert specifies ≤100 μg residual formaldehyde per 0.5 mL dose.

17. Mitkus, R. J., Hess, M. A., Schwartz, S. L. Pharmacokinetic modeling as an approach to assessing the safety of residual formaldehyde in infant vaccines. Vaccine, 2013; 31(25): 2738-2743. DOI: 10.1016/j.vaccine.2013.03.071. A PBPK (physiologically-based pharmacokinetic) model, not an empirical biodistribution study. Cited by the CDC and vaccine manufacturers as the principal defense of injected formaldehyde safety.